SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma. Daley BR, Sealover NE, Finniff BA, Hughes JM, et al. Cancer Res 2025;85:118-133.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Daley BR, Sealover NE, Finniff BA, Hughes JM, et al. SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma. Cancer Res 2025;85:118-133.
PMID: 39437166